GSK pursuing split as easing of COVID curbs aids earnings By Reuters
By Pushkala Aripaka and Ludwig Burger (Reuters) -Plans for GlaxoSmithKline to split in two are "well underway" it said on Wednesday after exceeding first-quarter earnings forecasts as an easing of COVID-19 curbs meant more clinic visits for critical treatments such as HIV and routine shots. GSK has fallen behind in the coronavirus vaccines race and its broader strategy has been under the microscope after a report that U.S. activist investor Elliott built up a significant stake. The British drugmaker said it would provide details on June 23 on its plan to separate next year into an...
Continue reading